Biopharmaceutical Analysis: Mass Spectrometry

Fresh insight is instrumental in the discussion of novel analytics.

Thermo Fisher and Symphogen have extended their collaboration involving improved data workflow, which supports the discovery and development of new cancer treatments.

A new portfolio of chromatography and mass spectrometry consumables launched by Thermo Fisher Scientific is designed to meet higher performance requirements while remaining economical.

The integration of modern software tools can make the acquisition and analysis of MS data more efficient, accurate, and compliant.

Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Thermo Fisher Scientific showcases its new mass spectrometry and chromatography solutions at the ASMS Conference on Oct. 31–Nov. 4, 2021.

CuriRx’s CuriLytics platform is a mass spectrometry instrument that will support complex biotherapeutics development.

Gene therapy products present a unique set of challenges for the control of host cell protein impurities.

Sophisticated analytical technologies are complementing traditional approaches in the identification of residual process-related impurities of biotherapeutics.

Microfluidic Modulation Spectroscopy is a recent innovation in infrared spectroscopy techniques that improves elucidation of secondary protein structure.

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

The need for real-time monitoring and control has spurred the development of new analytical tools.

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.

Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.

In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.

Analytical solutions are improving for raw material testing, process development, drug product release, and more.

Complex protein structures pose analytical challenges that can be addressed by advanced mass spectrometry technologies and workflows, which can be used to comprehensively characterize them.

The following details some of the latest tools and systems available for biopharmaceutical laboratory operations.

Effective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost.

Protagen Protein Services’ recently acquired Brucker Tensor II IR spectrometer significantly expands the company’s analytical capabilities.

Real-time monitoring of product- and process-related impurities remains a challenge.

Waters debuted a range of new TA Instruments innovations and the BioAccord System at Pittcon 2019 in Philadelphia, PA, on March 17–21, 2019.

Katalyst D2D from ACD/Labs enables the design, planning, execution, and analysis of high throughput (HT) experiments. The web-based application was introduced at Pittcon 2019 in Philadelphia, PA.

Leveraging vast quantities of analytical data requires digitalization and platform integration.

Determining a peptide’s purity is challenging because impurities are often structurally similar to each other and the API and can be present at very low concentrations. New approaches offer a solution.